Objective 1: Research
Identify and prioritize the research eligible to be conducted through the Coalition to develop a comprehensive evidence base on the short- and long-term health effects of marijuana for medical use, addressing the key gaps in the evidence base. All research conducted through the Coalition must be in compliance with the U.S. Drug Enforcement Administration (DEA) and the U.S. Food and Drug Administration (FDA) policies and regulations. Research conducted will, in addition, be approved by relevant Institutional Review Board/Institutional Animal Care and Use Committee (IRB/IACUC).
Prioritized research streams and objectives may include, but shall not be limited to:
1a. Observational/Survey Research:
1b. Education to improve knowledge of Health Professionals and the Public:
1c. Laboratory Research:
1d. Clinical Research:
1e. Health Policy and Health Economics Research:
Objective 2: Professional and Public Education
Build infrastructure to increase knowledge and understanding of current evidence on the short- and long-term health effects of marijuana use among health care professionals, policy makers, growers, marijuana dispensaries/pharms, public, patients and caretakers.
2a. Health Care Guidelines
2b. Research Quality
Conduct an annual, interactive workshop of multi-disciplinary leaders, to develop research standards and benchmarks to guide and ensure the production of high-quality medical marijuana research. Workshop objectives will include, but will not be limited to:
2c. Public Education
Objective 3: Regulatory Issues
Convene a committee of experts including researchers, clinicians (ASCO, APA, ANA), regulatory (DEA, FDA, DOH) and funding organizations (State of Florida, NIH-NIDA,NCI,NIA) and task them to produce objective and evidence-based reports that fully characterize the impacts of regulatory barriers and propose strategies to mitigate these barriers.
Committee objectives include, but are not be limited to proposing strategies to address: